Phase I and pharmacokinetic study of rhizoxin.

Phase I and pharmacokinetic study of rhizoxin.

Item
http://www.wikidata.org/entity/Q46563364
Multicentre phase II pharmacological evaluation of rhizoxin. Eortc early clinical studies (ECSG)/pharmacology and molecular mechanisms (PAMM) groupsStabilizing versus destabilizing the microtubules: a double-edge sword for an effective cancer treatment option?Microtubule-binding agents: a dynamic field of cancer therapeutics.Phase II clinical trials with rhizoxin in breast cancer and melanoma. The EORTC Early Clinical Trials Group.Phase II trials of rhizoxin in advanced ovarian, colorectal and renal cancer.Phase II study of rhizoxin in squamous cell head and neck cancer. The EORTC Early Clinical Trials Group.Single agent activity of rhizoxin in non-small-cell lung cancer: a phase II trial of the EORTC Early Clinical Trials Group.P glycoprotein (P-gp) and drug resistance--time for reappraisal?
P2860

Phase I and pharmacokinetic study of rhizoxin.

Item
http://www.wikidata.org/entity/Q46563364
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh-hant
name
Phase I and pharmacokinetic study of rhizoxin.
@en
Phase I and pharmacokinetic study of rhizoxin.
@nl
type
label
Phase I and pharmacokinetic study of rhizoxin.
@en
Phase I and pharmacokinetic study of rhizoxin.
@nl
prefLabel
Phase I and pharmacokinetic study of rhizoxin.
@en
Phase I and pharmacokinetic study of rhizoxin.
@nl
P1433
P1476
P2093
P304
P31
P407
P433
P478
P577
P698
P1433
P1476
Phase I and pharmacokinetic study of rhizoxin
@en
P2093
P304
P31
P407
P433
P478
P577
P698